Exosomal miR ‐128‐3p reversed fibrinogen‐mediated inhibition of oligodendrocyte progenitor cell differentiation and remyelination after cerebral ischemia
CNS Neuroscience & Therapeutics · 2023-05 · 29 (5) · 1405-1422
DOI: 10.1111/cns.14113 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.02.2023. Verfasst von Huiqing Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: MicroRNAs, Oligodendrocyte Precursor Cells, Remyelination, Brain Ischemia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To investigate the role of exosomal miR‐128‐3p in promoting fibrinogen‐mediated inhibition of oligodendrocyte progenitor cell (OPC) differentiation and the therapeutic potential of exosomal miR‐128‐3p in cerebral ischemia.
Methods
Mouse models of middle cerebral artery occlusion (MCAO) were established as described previously. MCAO was treated with fibrinogen and exosomes by stereotactically injecting into the left stratum. Mouse cortical OPCs were used for mRNA and miRNA sequencing analysis. Exosomes were isolated from neural stem cells (NSCs) of mice.
Results
Fibrinogen deposition suppressed remyelination after MCAO and inhibited OPC differentiation by activating ACVR1, the bone morphogenetic protein (BMP) signaling type I receptor. In vitro, miR‐sequencing and verification studies revealed that miR‐128‐3p is associated with BMP signaling mediated by ACVR1. Additionally, transfer of NSC‐derived exosomal miR‐128‐3p to OPCs significantly increased myelin basic protein expression and inhibited BMP signaling. Furthermore, NSC‐derived exosomal miR‐128‐3p protected against fibrinogen‐induced demyelination related to BMP signaling, reduced the infarct volume, and improved neurological function after MCAO.
Conclusions
Fibrinogen deposition inhibits remyelination after ischemic damage and NSC‐derived exosomal miR‐128‐3p promotes OPC differentiation into OLs by suppressing BMP signaling, indicating that NSC‐derived exosomal miR‐128‐3p represents a potential therapeutic target for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
- Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China.
- Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Huiqing Hou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hou, H., Wang, Y., Yang, L., & Wang, Y. (2023). Exosomal miR ‐128‐3p reversed fibrinogen‐mediated inhibition of oligodendrocyte progenitor cell differentiation and remyelination after cerebral ischemia. CNS Neuroscience & Therapeutics, 29(5), 1405-1422. https://doi.org/10.1111/cns.14113
Vancouver
Hou H, Wang Y, Yang L, Wang Y. Exosomal miR ‐128‐3p reversed fibrinogen‐mediated inhibition of oligodendrocyte progenitor cell differentiation and remyelination after cerebral ischemia. CNS Neuroscience & Therapeutics. 2023;29(5):1405-1422. doi:10.1111/cns.14113
BibTeX
@article{Hou2023,
author = {Hou, Huiqing and Wang, Yafei and Yang, Lan and Wang, Yongjun},
title = {Exosomal miR ‐128‐3p reversed fibrinogen‐mediated inhibition of oligodendrocyte progenitor cell differentiation and remyelination after cerebral ischemia},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
volume = {29},
number = {5},
pages = {1405--1422},
doi = {10.1111/cns.14113}
}
EUVIMED